Navigation Links
Sunesis Pharmaceuticals to Present at Healthcare Investor Conferences in March
Date:3/13/2008

SOUTH SAN FRANCISCO, Calif., March 13 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Daniel Swisher, Sunesis' Chief Executive Officer and President, will provide a corporate overview at two upcoming investor conferences in March.

-- Mr. Swisher will speak at the Cowen and Company 28th Annual Health Care

Conference at 8:45 a.m. Eastern Time on Tuesday, March 18, 2008 at the

Boston Marriott Copley Place in Boston, Mass.

-- On Thursday, March 20, 2008, Mr. Swisher will present at the Lehman

Brothers Eleventh Annual Global Healthcare Conference at 12:45 p.m.

Eastern Time in Miami, Fla.

Interested parties may access a webcast of each the presentations by visiting the Sunesis website at http://ir.sunesis.com. A replay of the webcasts will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule therapeutics for oncology and other serious diseases. Sunesis has built a broad product candidate portfolio through internal discovery and in-licensing of novel cancer therapeutics. Sunesis is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies. For further information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.


'/>"/>
SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
3. Sunesis Pharmaceuticals SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... 15, 2014 Emergo Group, Inc., a ... countries in North and South America, Europe, the Middle ... industry participants for its 2015 Medical Device Industry Survey. ... identify upcoming business and market trends as well as ... survey targets areas including:, , Overall ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 At the ... organizations AutismOne and Focus Autism ... attendees with research on the effects of toxins to ... and intervention information. , Luminaries such as Dr. ... from abroad with esteemed, credentialed colleagues of the United ...
(Date:12/15/2014)... IL (PRWEB) December 15, 2014 Kenmode ... joined the firm as Director of Quality Assurance. ... managing quality systems, processes and certifications for manufacturers in ... the posts of Corporate Quality Manager at Sonoco Products ... Quality at NetCom, Inc., and Quality Assurance Manager for ...
(Date:12/15/2014)... Angeles, CA (PRWEB) December 15, 2014 ... score of 3.3 out of 5. This score indicates ... with regard to negotiating prices. “Suppliers have been raising ... years to 2014, largely due to rising demand,” according ... benefit from low price volatility. , During the past ...
(Date:12/15/2014)... 2014 Tbdress.com has recently announced its ... up to 80% off. Orders above $99 come with ... A-line wedding dresses , lace wedding dresses ... of wedding gowns and women’s special occasion outfits, has ... product line. Handpicked by skilled dress experts, all the ...
Breaking Medicine News(10 mins):Health News:Emergo’s Annual Survey Assessing the State of the Medical Device Industry Now Open 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3Health News:Kenmode Precision Metal Stamping Appoints Abid Rashid as Director of Quality Assurance 2Health News:Metal Drilling Machines Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Metal Drilling Machines Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Tbdress.com: No-cost Shipping Day Sales Online Now 2
... face higher risk, study finds, , , MONDAY, May 18 (HealthDay News) ... likely than other teens to attempt suicide, according to a U.S. ... to determine if there,s a link between suicide attempts and body ... or she might be overweight -- whether it,s true or not. ...
... to Achieve Health Care ReformMINNEAPOLIS, May 18 Target ... it has become a founding member of the Alliance ... to help U.S. citizens become more physically and emotionally ... the healthiest nation in a healthier world. It strives ...
... has redesigned its website to improve navigation, functionality and user-friendliness. ... travel insurance plans, but with better design and navigation, users ... easily. , ... Neptune Beach, FL ...
... of Upcoming ASCO PresentationBELLEVUE, Wash., May 18 Light ... preclinical study has yielded evidence that the company,s novel ... and prevent metastases. Results of the study will be ... Society of Clinical Oncology (ASCO) meeting in Orlando, Florida, ...
... For Physically Able 50+ Adults To Promote Better Health, Exercise And ... are age 50+, you are eligible to take an amazing virtual ... of Vermont and ends in fabulous Las Vegas - all without ... are a Boomer, Zoomer, Red Hat or Silver Fox, log on ...
... Derma Sciences, Inc. (OTC Bulletin Board: DSCI), ... for the first quarter ended March 31, 2009. For ... versus $11.7 million in the first quarter 2008. The sales ... associated with a significant weakening in the Canadian dollar and ...
Cached Medicine News:Health News:Worries About Weight Are Tied to Teen Suicide Tries 2Health News:Target Corporation Joins Alliance to Make US Healthiest 2Health News:International Student Insurance Announces Website Redesign 2Health News:Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer 2Health News:Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer 3Health News:Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer 4Health News:Cabot Creamery Cooperative's 'Vermont to Vegas' Online Health and Fitness Challenge is a Virtual Blast 2Health News:Cabot Creamery Cooperative's 'Vermont to Vegas' Online Health and Fitness Challenge is a Virtual Blast 3Health News:Derma Sciences Reports First Quarter 2009 Results 2Health News:Derma Sciences Reports First Quarter 2009 Results 3Health News:Derma Sciences Reports First Quarter 2009 Results 4Health News:Derma Sciences Reports First Quarter 2009 Results 5Health News:Derma Sciences Reports First Quarter 2009 Results 6
(Date:12/15/2014)... Investor-Edge has initiated coverage on the following equities: ... Company (NYSE: LLY ), Nektar Therapeutics (NASDAQ: ... Novartis AG (NYSE: NVS ). Free research on ... . On Friday, December 12, 2014, the NASDAQ Composite ... lost 1.79%, to finish the day at 17,280.83, and the ...
(Date:12/15/2014)... Dec. 15, 2014  The Government of Ghana ... Global Blood Fund (GBF) and Terumo BCT to respond to the ... well as provide long-term health system capacity to the citizens of ... , The Ghanaian Ebola Readiness and Resilience Initiative (GERRI) is a ... preparations for the possible arrival of the Ebola epidemic ...
(Date:12/13/2014)... Research and Markets ( ... the  "Global Catheters Market (Product Types and ... Profiles, Analysis, Segmentation and Forecast, 2013 - ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,Catheters ... grade material such as plastic, silicon rubber, ...
Breaking Medicine Technology:Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 4Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 6Global Catheters Market (Product Types and Geography) - Forecast to 2020 2Global Catheters Market (Product Types and Geography) - Forecast to 2020 3
... Data Shows Long-term Improvements in Productivity, Quality of ... American College ... Oct. 27 5:00 AM PST -- UCB announced,today ... pegol) - the only PEGylated anti-TNF (Tumor Necrosis Factor),- ...
... SOUTH SAN FRANCISCO, Calif., Oct. 26 Monogram,Biosciences, ... data presented this,week demonstrated that in Pfizer Inc,s ... (maraviroc) in treatment naive individuals with CCR5-tropic,HIV-1, increased ... enrichment of the,patient population by use of the ...
Cached Medicine Technology:CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 2CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 3CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 4CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 5CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 6CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 7CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 8CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 9CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 10Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 2Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 3Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 4Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 5Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 6
This compression garment can be used immediatlely following Abdominoplasty, Tram Flap, Abdominal Liposuction, Lipoplasty, Suction Lipectomy, Stomach Liposuction, Liposculpture and Tummy Tuck procedur...
Black Spandex Above the Knee Compression Girdles with Contact Closure with Zipper...
Bodyshaper For Men...
Ideal for abdominal, hip, thigh and knee procedures....
Medicine Products: